Synthetic Dataset Generation

KerusCloud® can be used to generate highly realistic synthetic datasets for use in a wide variety of analytics applications in the life sciences sector and beyond.

The KerusCloud® platform has proved to be a core part of our decision-making as it allows us to prospectively tailor study designs as new information becomes available.
Biotech, UK
Chief Medical Officer

Generate Synthetic Clinical Data for Smarter, Safer Research

KerusCloud® offers advanced synthetic data generation for clinical research, helping teams simulate realistic patient-level datasets without compromising privacy. Whether you’re designing trials, building external control arms, or training AI models, KerusCloud® enables you to generate high-quality data that mirrors real-world conditions. This empowers faster, safer decision-making—especially when access to real data is limited, sensitive, or incomplete.


What is synthetic data?

Synthetic data is data which has been generated using purpose-built computer simulations, mathematical/statistical models or algorithms. Synthetic data is generated to meet specific needs or certain conditions that may not be found in the original, real data. It has many applications across multiple industries including:

  • Market research and business intelligence
  • Testing and validating software products and systems
  • Building and testing algorithms
  • Predictive modelling, machine learning and AI

When is it useful for clinical trials?

Synthetic data is useful in clinical research, where it can be used:

  • In clinical trial design optimization to maximize chance of success.
  • To create external control arms for clinical trials to save time and resources.
  • In anonymization to enable the sharing of regulated or sensitive data.
  • To create large, auto labelled data for predictive modelling, machine learning and AI to address issues of imbalanced data.

How do we create it?

Within KerusCloud® is a synthetic data generator. It can handle diverse and complex data collected from disparate data sources and produce synthetic datasets from them. KerusCloud’s exceptional modelling capability allows it to incorporate realistic characteristics into the synthetic datasets it produces such as missing data, truncation and censoring. It can model the inter-correlation between subject-level data such as subgroups and strata, risk factors/covariates and multiple outcomes and data types. This delivers a highly realistic synthetic version of the original data.

Suggested For You

perspectives

March 12th, 2026

AI in Pharma: Autopilot Is Not the Same as Removing the Pilot 

webinar

April 16th, 2026

Inside FDA REMS Decision-Making: A Fireside Chat for Sponsors

perspectives

March 3rd, 2026

Modeling and Simulation in Clinical Trials: A Practical Approach to De-Risking Study Design

perspectives

February 25th, 2026

Integrating AI and Automation Into Clinical Trial Operations With Discipline and Transparency

perspectives

February 10th, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

February 5th, 2026

MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions 

perspectives

February 3rd, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

January 29th, 2026

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

ebook

January 27th, 2026

A Practical Guide to Expedited Regulatory Pathways

perspectives

January 27th, 2026

What Regulators Want to See in Surrogate Endpoints Today 

perspectives

January 20th, 2026

Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration 

perspectives

January 13th, 2026

Making Clinical Trial Technology Work in Practice